Evidence map›Paper›PMID 35328517›Full record

ArticleInternational journal of molecular sciences2022

Somatostatin Primes Endothelial Cells for Agonist-Induced Hyperpermeability and Angiogenesis In Vitro.

Muhammad Aslam, Hafiza Idrees, Peter Ferdinandy, Zsuzsanna Helyes, Christian Hamm, Rainer Schulz

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Muhammad AslamExperimental Cardiology, Department of Cardiology and Angiology, Justus Liebig University, Aulweg 129, 35392 Giessen, Germany.ORCID 0000-0002-8529-4217
Hafiza IdreesExperimental Cardiology, Department of Cardiology and Angiology, Justus Liebig University, Aulweg 129, 35392 Giessen, Germany.
Peter FerdinandyDepartment of Pharmacology and Pharmacotherapy, Semmelweis University, 1089 Budapest, Hungary.
Zsuzsanna HelyesDepartment of Pharmacology and Pharmacotherapy, Medical School and Szentágothai Research Centre, University of Pécs, 7624 Pécs, Hungary.
Christian HammExperimental Cardiology, Department of Cardiology and Angiology, Justus Liebig University, Aulweg 129, 35392 Giessen, Germany.
Rainer SchulzInstitute of Physiology, Justus Liebig University, 35392 Giessen, Germany.ORCID 0000-0003-3017-0476
Justus-Liebig-Universität Gießen · DESemmelweis University · HUUniversity of Pecs · HU

Funding

Semmelweis University CA16225University of Giessen None
6 · The paper itself

Abstract

Somatostatin is an inhibitory peptide, which regulates the release of several hormones, and affects neurotransmission and cell proliferation via its five G

Indexed as

Proto-Oncogene Proteins c-aktVascular Endothelial Growth Factor ACells, CulturedHumansHuman Umbilical Vein Endothelial CellsMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase KinasesNeovascularization, PathologicSomatostatinThrombinMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase KinasesProto-Oncogene Proteins c-aktSomatostatinThrombinVascular Endothelial Growth Factor AAktangiogenesiscAMPendothelial permeabilityMAPKMYPT1RhoA/Rocksomatostatin receptors

Identifiers

PMID35328517
PMCPMC8949535
OpenAlexW4220660052

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.